Japanese Tobacco Stock News

TSE:6301
TSE:6301Machinery

How Komatsu’s Large Cancellation-Backed Buyback And 2027 Outlook At Komatsu (TSE:6301) Has Changed Its Investment Story

In April 2026, Komatsu Ltd. announced it would repurchase up to 25,000,000 shares for ¥100,000 million, cancel the repurchased stock, reported full-year 2026 earnings of ¥4,132,751 million in sales and ¥376,391 million in net income, and issued guidance and dividend plans for fiscal 2027. This combination of a sizeable cancellation-backed buyback and detailed earnings and dividend outlook provides fresh insight into how Komatsu is balancing capital returns with reinvestment needs. We will...
TSE:4502
TSE:4502Pharmaceuticals

Is TAK-881’s Reduced-Volume PID Infusion Data Altering The Investment Case For Takeda (TSE:4502)?

Earlier this month, Takeda Pharmaceutical reported that its pivotal Phase 2/3 trial of investigational PID therapy TAK-881 met its primary pharmacokinetic endpoint, showing comparable IgG exposure, efficacy and safety to HYQVIA, while potentially allowing patients to receive equivalent immunoglobulin doses in roughly half the infusion volume. Because TAK-881 may offer shorter, lower-volume infusions with once-monthly flexibility, it could meaningfully change treatment convenience for Primary...
TSE:7970
TSE:7970Chemicals

Assessing Shin-Etsu Polymer (TSE:7970) Valuation After Full Year 2026 Earnings And Dividend Review

Earnings and dividend review put Shin-Etsu PolymerLtd (TSE:7970) in focus Shin-Etsu PolymerLtd (TSE:7970) has just reported full year results to March 31, 2026 and held a board meeting to consider revising its dividend forecast, putting earnings quality and shareholder returns under closer investor scrutiny. See our latest analysis for Shin-Etsu PolymerLtd. The recent earnings announcement and board meeting on the dividend forecast came against a strong backdrop, with Shin-Etsu PolymerLtd’s...
TSE:8604
TSE:8604Capital Markets

Assessing Nomura Holdings (TSE:8604) Valuation After Recent Share Price Weakness

Nomura Holdings (TSE:8604) drew fresh attention after recent share price weakness, with the stock showing negative returns over the past week, month, and past 3 months, prompting investors to reassess its longer term performance. See our latest analysis for Nomura Holdings. Short term momentum looks weak, with the share price down over the past week and quarter. However, the 1 year total shareholder return of 59.65% and 3 year total shareholder return of 188.07% still indicate a strong longer...
TSE:4911
TSE:4911Personal Products

Assessing Shiseido Company (TSE:4911) Valuation After New ¥300b Bond Shelf Filing

What Shiseido’s New Bond Shelf Could Mean for the Stock Shiseido Company (TSE:4911) has filed a shelf registration to issue up to ¥300 billion in bonds, a move that gives the company flexibility to raise debt funding when conditions appear favorable. For you as a shareholder or potential investor, this filing matters because it may influence Shiseido’s future capital structure, interest costs, and capacity to fund projects, acquisitions, or balance sheet adjustments, without immediately...
TSE:4568
TSE:4568Pharmaceuticals

Evaluating Daiichi Sankyo (TSE:4568) As Oncology Expectations Fuel Undervaluation Claims

Oncology pipeline expectations draw fresh focus to Daiichi Sankyo Positive sentiment around Daiichi Sankyo Company (TSE:4568) is being driven by expectations that its oncology portfolio, including upcoming pivotal data and regulatory submissions across several cancer types, could reshape how investors view the stock. See our latest analysis for Daiichi Sankyo Company. Despite the excitement around its oncology portfolio, Daiichi Sankyo’s share price return has been weak, with an 8.45% 1 month...
TSE:8053
TSE:8053Trade Distributors

Sumitomo (TSE:8053) Is Up 17.9% After Launching New Buyback, Split And Medium-Term Plan

Sumitomo Corporation recently reported full-year results to March 31, 2026, with revenue of ¥7,337,259 million and net income of ¥600,334 million, while also approving a share repurchase program of up to 22,000,000 shares, or 1.84% of outstanding stock, worth ¥80,000 million through March 31, 2027. Alongside higher earnings, Sumitomo outlined a Medium-Term Management Plan 2026, raised its dividend, and announced a four-for-one share split, underscoring an emphasis on capital efficiency and...
TSE:4523
TSE:4523Pharmaceuticals

Is Eisai (TSE:4523) Pricing Reflect Its DCF Discount And LEQEMBI Headlines

Wondering if Eisai's share price really reflects what you are getting for your money? This article walks through how its current valuation stacks up against several common yardsticks. Over the last year the stock returned 19.1%, but recent moves have been choppy, with a 1.8% gain over 7 days, an 8.8% decline over 30 days and a 2.1% decline year to date from a last close of ¥4,688. Recent headlines around Eisai have continued to focus on its role in pharmaceuticals and biotechnology, keeping...
TSE:6758
TSE:6758Consumer Durables

Low Risk Leaders Quietly Hiding Cash Rich Growth Stories

Markets are being pulled in different directions by higher oil prices, sticky inflation signals, and shifting rate expectations across the US, Europe, and Asia. In this kind of cross-current, many investors are looking for solid footing rather than the next hot story. That is where the Low-Risk Leaders screener comes in, focusing on companies with resilient balance sheets and lower model risk scores that can help anchor a portfolio while maintaining a focus on attractive returns. In this...
TSE:9984
TSE:9984Wireless Telecom

Is It Too Late To Consider SoftBank Group (TSE:9984) After Its 193% One Year Surge?

If you are wondering whether SoftBank Group's rapid swings in sentiment point to a bargain or a bubble, this article focuses squarely on what the current share price might really represent. The stock last closed at ¥5,424, with returns of 3.0% over 7 days, 48.7% over 30 days, 17.5% year to date, 193.3% over 1 year and 143.4% over 5 years. That puts recent moves front and center in any valuation conversation. Those price shifts sit against a backdrop of ongoing headlines about SoftBank...
TSE:6971
TSE:6971Electronic

Should Kyocera’s New ¥250 Billion Buyback and Profit Lift Require Action From Kyocera (TSE:6971) Investors?

In April 2026, Kyocera Corporation announced a share repurchase program of up to 156,544,000 shares for ¥250,000,000,000, alongside full-year results showing higher sales and net income compared with the prior year. Together with a board review of its Articles of Incorporation and dividend policy, these moves highlight Kyocera’s focus on capital flexibility and shareholder returns while advancing ceramic substrates for AI-focused semiconductor packaging. We’ll now examine how Kyocera’s...
TSE:7203
TSE:7203Auto

Is It Time To Reassess Toyota Motor (TSE:7203) After The Recent Share Price Pullback

Wondering whether Toyota Motor's current share price actually lines up with its underlying worth, or if the stock is starting to look stretched or overlooked? The stock last closed at ¥3,000.0, with returns of a 3.6% decline over 7 days, a 7.8% decline over 30 days, an 11.7% decline year to date, 11.2% over 1 year, 70.5% over 3 years and 107.2% over 5 years. Recent headlines around Toyota Motor have focused on ongoing product developments, investment priorities and the broader auto sector's...
TSE:5332
TSE:5332Building

TOTO (TSE:5332) Is Up 18.4% After Semiconductor Ceramics-Driven EPS Lift And Dividend Move – Has The Bull Case Changed?

TOTO LTD. reported full-year results for the period ended March 31, 2026, with sales of ¥737,441 million and net income of ¥40,257 million, and its board met on April 30, 2026 to consider a year-end dividend with a March 31, 2026 record date. A key highlight was the strong contribution from TOTO’s semiconductor ceramics business, which helped lift earnings per share from continuing operations to about ¥243 on both a basic and diluted basis. We’ll now explore how this earnings performance,...
TSE:6526
TSE:6526Semiconductor

Does Socionext’s 2026 Results and 2027 Guidance Reshape The Bull Case For Socionext (TSE:6526)?

Socionext Inc. recently reported full-year results for the period ended March 31, 2026, with higher sales of ¥200,834 million but lower net income of ¥8,733 million year on year, reaffirmed an annual dividend of ¥25.00 per share, and issued earnings guidance for fiscal 2027. Amid this mix of revenue growth, profit compression, and an unchanged dividend, Socionext’s forward guidance for ¥215,000 million in net sales and basic EPS of ¥57.05 offers fresh context for how management is...
TSE:9020
TSE:9020Transportation

East Japan Railway (TSE:9020) Is Up 7.2% After Dividend Hike And Suica Expansion Push Has The Bull Case Changed?

East Japan Railway Company has already reported full-year 2026 results, with sales rising to ¥3,084.68 billion and net income reaching ¥247.85 billion, alongside a higher year-end dividend and plans to gradually lift its payout ratio. Beyond rail operations, the company is using its stronger earnings to accelerate expansion of Suica-based transaction and personal finance services, aiming to deepen customer engagement and diversify income sources. We’ll now examine how the dividend increase...
TSE:7309
TSE:7309Leisure

Stronger Q1 Results And Guidance Could Be A Game Changer For Shimano (TSE:7309)

Shimano Inc. has already reported first-quarter 2026 results, with sales rising to ¥117,644 million and net income increasing to ¥12,814 million, and its board considering the disposal of treasury shares as restricted stock remuneration. The company also raised its earnings guidance for 2026, with the higher net income outlook driven partly by gains on sales of cross-shareholdings booked as extraordinary income. We will now examine how Shimano’s stronger first-quarter earnings and upgraded...
TSE:2768
TSE:2768Trade Distributors

How Sojitz’s Higher Revenue and Softer Earnings Shape Its Dividend Focus for (TSE:2768) Investors

Sojitz Corporation recently reported full-year results for the 12 months to March 31, 2026, with revenue rising to ¥2,757.35 billion while net income eased to ¥103.61 billion, alongside slightly lower basic and diluted earnings per share from continuing operations. On the same day, the board met to discuss year-end and interim cash dividends, signaling continued attention to shareholder returns despite softer profitability. With earnings growth in revenue but a dip in net income, we’ll now...
TSE:8136
TSE:8136Specialty Retail

Assessing Sanrio Company (TSE:8136) Valuation After Board Delays Results And Launches Special Investigation Committee

Board decision and why it matters for Sanrio stock Sanrio Company (TSE:8136) has attracted investor attention after its board decided to postpone announcing financial results for the year ended March 2026 and to set up a Special Investigation Committee. See our latest analysis for Sanrio Company. The board announcement comes after a period of weaker momentum in the share price, with a 7 day share price return of 6.35% and a 30 day share price return of 8.31%. The 1 year total shareholder...
TSE:6645
TSE:6645Electronic

Is OMRON (TSE:6645) Using Virtual Twins To Quietly Redefine Its Automation Moat?

Dassault Systèmes and OMRON recently announced a partnership that links Dassault’s 3D virtual twin technology with OMRON’s Sysmac industrial automation platform, enabling manufacturers to design, simulate, and validate production systems in a unified virtual-physical environment. A distinctive aspect of this collaboration is the continuous feedback loop between real-time sensor and robot data and the virtual twin, which can improve system optimization, safety testing, and maintenance...
TSE:4151
TSE:4151Pharmaceuticals

Did Kyowa Kirin's (TSE:4151) New NPM1‑Mutated AML Trial Just Reframe Its Oncology Ambitions?

Kyowa Kirin and Kura Oncology recently dosed the first patient in a Japanese Phase 2 registrational trial of ziftomenib, an oral menin inhibitor, for adults with relapsed or refractory NPM1‑mutated acute myeloid leukemia, following its prior approval in the US as KOMZIFTI. This trial targets a genetic subtype representing around 30% of AML cases in Japan and could support Kyowa Kirin’s planned regulatory filing, while also extending the clinical footprint of a therapy already in use...
TSE:7911
TSE:7911Commercial Services

Assessing TOPPAN Holdings (TSE:7911) Valuation After Its HAPS Materials Breakthrough With SoftBank

TOPPAN Holdings (TSE:7911) is back in focus after working with SoftBank Corp. on lightweight, highly durable wing skin for solar powered High Altitude Platform Station aircraft, a project related to future communications infrastructure. See our latest analysis for TOPPAN Holdings. The recent HAPS materials breakthrough and ongoing packaging initiatives come alongside strong momentum in TOPPAN Holdings' share price, with an 18.11% 1 month share price return and a 28.42% 1 year total...
TSE:4519
TSE:4519Pharmaceuticals

Asian Market Highlights 3 Stocks Estimated Below Their Intrinsic Value

As global markets navigate through a period of heightened geopolitical tensions and economic uncertainties, Asian markets have shown resilience with stable performances and strategic policy adjustments. In this environment, identifying stocks that are potentially undervalued can be an effective strategy for investors looking to capitalize on market inefficiencies.